A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma

被引:11
|
作者
Zhao, Kai [1 ]
Li, Xiangyu [1 ]
Shi, Yuanxin [1 ]
Lu, Yun [1 ]
Qiu, Peng [1 ]
Deng, Zhengdong [1 ]
Yao, Wei [2 ]
Wang, Jianming [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Biliary & Pancreat Surg,Canc Res Ctr, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[3] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; pyroptosis; lncRNAs; prognosis; tumor immune microenvironment; immunotherapy; CELL-DEATH; CANCER STATISTICS; PROMOTES; PATHWAY;
D O I
10.3389/fgene.2022.899496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Globally, pancreatic adenocarcinoma (PAAD) is a common and highly devastating gastrointestinal malignancy that seriously threatens human health. Pyroptosis refers to an emerging form of programmed cell death that has been discovered in recent years, and studies have demonstrated that long non-coding RNA (lncRNA) may act as a moderator in the pyroptosis process of cancer cells. However, relevant explorations about lncRNAs and pyroptosis are still insufficient in PAAD. Therefore, our research is designed to make a comprehensive analysis of the potential values of pyroptosis-related lncRNAs in PAAD.Methods: By integrating the RNA-sequencing, somatic mutation, and copy number variation (CNV) datasets, as well as the clinicopathological features, we established and validated a risk signature based on pyroptosis-related lncRNAs, and comprehensively analyzed its clinical significance and the potential connection with the tumor immune microenvironment (TIME).Consequences: The genetic variation landscape displayed that the somatic mutations were rare while CNV changes were general and mainly concentrated on copy number amplification of these 52 pyroptosis-related genes. Subsequently, a risk signature consisting of 10 lncRNAs (TRAF3IP2-AS1, LINC00519, LINC01133, LINC02251, AC005332.6, AL590787.1, AC090114.2, TRPC7-AS1, MIR223HG, and MIR3142HG) was constructed and patients were divided into different subgroups according to the median risk score; patients with high-risk scores presented worse outcomes compared to those with low-risk scores in the training, testing, and entire cohorts. Furthermore, patients at low-risk scores possessed a higher infiltration abundance of immune cells compared with high-risk patients, which was consistent with the expression levels of lncRNAs between the high/low-risk groups. Drug sensitivity analysis showed that low-risk scores were related to anti-cancer agents like AICAR and Axitinib, whereas high-risk scores were connected with certain drugs such as AUY922. These results demonstrated that our risk signature could be used for prognosis prediction; additionally, it was also related to the TIME that might act as a potential indicator to instruct immunotherapeutic strategies.Conclusion: This work explored the significance of the risk model constructed by pyroptosis-related lncRNAs in prognosis prediction and its internal link with the immune microenvironment of PAAD. The results are expected to assist in the diagnosis, prognostic assessment, and management of patients with PAAD.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma
    Zhong, Jia'nan
    Wang, Zheng
    Hounye, Alphonse Houssou
    Liu, Jing
    Zhang, Jianglin
    Qi, Min
    LIFE SCIENCES, 2022, 307
  • [32] Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
    Zeng, Ruijie
    Huang, Shujie
    Qiu, Xinqi
    Zhuo, Zewei
    Wu, Huihuan
    Jiang, Lei
    Sha, Weihong
    Chen, Hao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [33] Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma
    Gong, Zetian
    Li, Qifan
    Yang, Jian
    Zhang, Pengpeng
    Sun, Wei
    Ren, Qianhe
    Tang, Junjie
    Wang, Wei
    Gong, Hui
    Li, Jun
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [34] A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma
    Wu, Chunting
    Zhao, Jiahui
    Wang, Xinxia
    Wang, Yan
    Zhang, Wenmei
    Zhu, Guangfa
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (08) : 2647 - +
  • [35] Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis
    Liu, Li
    Chen, Chenxi
    Tu, Gang
    Peng, Yang
    Shen, Meiying
    Xu, Yingkun
    Liu, Shengchun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [36] Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature
    Zhang, Ze
    Shang, Jin
    Hu, Bingyang
    Shi, Huizhong
    Cao, Yinbiao
    Li, Junfeng
    Jiao, Tianyu
    Zhang, Wenwen
    Lu, Shichun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients
    Zhang, Mengjiao
    Zhang, Jiqiang
    Liang, Xuemei
    Zhang, Ming
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [38] Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma
    Zhang, Feng
    Deng, Yan
    Wang, Dong
    Wang, Shuai
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [39] Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
    Huang, Qianrong
    Yan, Jun
    Jiang, Qian
    Guo, Fangzhou
    Mo, Ligen
    Deng, Teng
    MEDICINE, 2023, 102 (06)
  • [40] Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma
    Feng Zhang
    Yan Deng
    Dong Wang
    Shuai Wang
    Scientific Reports, 12